|
MRPS22 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.056200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.483800E-01 |
| Normal-vs-Stage2 |
4.326000E-01 |
| Normal-vs-Stage3 |
3.566600E-01 |
| Normal-vs-Stage4 |
7.260800E-01 |
| Stage1-vs-Stage2 |
5.383600E-01 |
| Stage1-vs-Stage3 |
3.828000E-01 |
| Stage1-vs-Stage4 |
6.913000E-01 |
| Stage2-vs-Stage3 |
2.038600E-01 |
| Stage2-vs-Stage4 |
4.290600E-01 |
| Stage3-vs-Stage4 |
8.809000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.826400E-01 |
| Normal-vs-AfricanAmerican |
7.545800E-01 |
| Normal-vs-Asian |
8.242200E-01 |
| Caucasian-vs-AfricanAmerican |
7.542600E-01 |
| Caucasian-vs-Asian |
7.914200E-01 |
| AfricanAmerican-vs-Asian |
8.711600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.094800E-01 |
| Normal-vs-Female |
4.558400E-01 |
| Male-vs-Female |
3.326800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.446600E-01 |
| Normal-vs-Extreme_Weight |
7.538400E-01 |
| Normal-vs-Obese |
3.497400E-01 |
| Normal-vs-Extreme_Obese |
5.208400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.753400E-01 |
| Normal_Weight-vs-Obese |
6.184400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.877600E-01 |
| Extreme_Weight-vs-Obese |
5.658600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.740200E-01 |
| Obese-vs-Extreme_Obese |
3.715600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.952800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.637400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.600800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.037800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.747400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.178000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.540600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.648800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.946200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.158400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.127000E-01 |
| Normal-VS-Type2 PRCC |
6.234400E-01 |
| Normal-VS-KIRP CIMP |
2.930400E-02 |
| Normal-VS-Unclassified PRCC |
4.473600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.695240E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.427670E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.666220E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.878170E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.822600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.422000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.774800E-01 |
| Normal-vs-N1 |
3.793800E-01 |
| Normal-vs-N2 |
1.544840E-01 |
| N0-vs-N1 |
9.374000E-01 |
| N0-vs-N2 |
8.416300E-02 |
| N1-vs-N2 |
4.528200E-02 |
|
|
